))
BioChat #7: Harnessing the Immune System to Fight Cancer -- From ABclonal Technology
Manage episode 371124094 series 3464173
Inhalt bereitgestellt von ABclonal Technology. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von ABclonal Technology oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
The immune system is now a key tool in developing personalized targeted therapies against many types of cancer. With an extensive background in immunology in the context of human disease, Philip Liu, Ph.D., joins BioChat to discuss a promising new drug against bladder cancer, and his unique career path towards this latest achievement.
Phil and Kin talk about our shared love of science, albeit with different career paths and methodologies to promote scientific breakthroughs, and advice for aspiring biomedical researchers. We also discuss the challenges in obtaining research funding and how the funding mechanism needs to adapt to continue attracting bright minds to academia to train the next generation of great scientists. Phil also asks what it is Kin actually does here!
Of course, we also talk about the exciting new IL-15-based therapy developed by Phil's company, ImmunityBio, as they have very promising results and are working towards clinical trials.
Please feel free to visit us at www.abclonal.com, read our blog posts here, including a look at the study of IL-15 as an immunotherapy, and check out our Doctor Beaker page for fun activities! You can also find all the ways to subscribe to our podcast via our BioChat page, which includes Apple Podcasts and Spotify.
28 Episoden
Teilen
